Please use this identifier to cite or link to this item:
|Title:||Potential roles for the PIM1 kinase in human cancer - A molecular and therapeutic appraisal|
|Authors:||Shah, N. |
|Citation:||Shah, N., Yeoh, K.-G., Chen, C.S., Salto-Tellez, M., Thorn, S., Lilly, M.B. (2008). Potential roles for the PIM1 kinase in human cancer - A molecular and therapeutic appraisal. European Journal of Cancer 44 (15) : 2144-2151. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ejca.2008.06.044|
|Abstract:||In vitro experiments have shown the PIM1 kinase to have diverse biological roles in cell survival, proliferation and differentiation. In humans, PIM1 is often expressed in both normal and transformed cells. The PIM1 kinase is a true oncogene implicated in early transformation and tumour progression in haematopoietic malignancies and prostate carcinomas. It is associated with aggressive subgroups of lymphoma, is a marker of poor prognosis in prostate carcinomas and has been suggested to have a role in hormone insensitivity of prostate malignancies. PIM1 has a possible role in other carcinomas with 6p21 genomic alterations. On one hand, PIM1 (due to its role in malignancy) appears to be a promising target for drug development programmes but, on the other hand, the complexity of its molecular structure has posed challenges in the development of PIM1 inhibitors. In this review we discuss PIM1 expression in human tissues (including some new data from our laboratory), its role in human malignancies, as well as the possibilities and challenges in the development of target therapy for PIM1. © 2008 Elsevier Ltd. All rights reserved.|
|Source Title:||European Journal of Cancer|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on May 20, 2018
WEB OF SCIENCETM
checked on Apr 18, 2018
checked on May 26, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.